Inventor
SCHOLTE ANDREW
US12 patents
⚠️ This page may combine multiple inventors who share the name “SCHOLTE ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENZYME CORP
9 patentsUS9611265B2Apr 4, 2017
Tropomyosin-related kinase (TRK) inhibitors
GENZYME CORP11 citations91
US9174986B2Nov 3, 2015
Tropomyosin-related kinase (Trk) inhibitors
GENZYME CORP13 citations91
US9067914B1Jun 30, 2015
Tropomyosin-related kinase (TRK) inhibitors
GENZYME CORP15 citations91
US11878024B2Jan 23, 2024
Tropomyosin-related kinase (Trk) inhibitors
GENZYME CORP3 citations84
US11406644B2Aug 9, 2022
Tropomyosin-related kinase (TRK) inhibitors
GENZYME CORP5 citations83
US10166239B2Jan 1, 2019
Tropomyosin-related kinase (Trk) inhibitors
GENZYME CORP9 citations83
US12318392B2Jun 3, 2025
Tropomyosin-related kinase (trk) inhibitors
GENZYME CORP1 citations73
US11274108B2Mar 15, 2022
Colony stimulating factor-1 receptor (CSF-1R) inhibitors
GENZYME CORP2 citations70
US12503477B2Dec 23, 2025
Colony stimulating factor-1 receptor (CSF-1R) inhibitors
GENZYME CORP0 citations59
CELGENE CAR LLC
3 patentsUS9663524B2May 30, 2017
Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors
CELGENE CAR LLC15 citations82
US10065966B2Sep 4, 2018
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
CELGENE CAR LLC2 citations71
US10618902B2Apr 14, 2020
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
CELGENE CAR LLC0 citations51